tiprankstipranks
BeOne Medicines Ltd (HK:6160)
:6160
Hong Kong Market
6160
BeOne Medicines Ltd
RESEARCH TOOLSreports

BeOne Medicines Ltd (6160) Stock News & Sentiment

22 Followers
BeOne Medicines Grants RSUs to 154 Employees Under 2016 Incentive Plan
Premium
Company Announcements
BeOne Medicines Grants RSUs to 154 Employees Under 2016 Incentive Plan
6d ago
6160
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
Premium
Ratings
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
18d ago
ONC
BeOne Medicines Swings to Profit on 40% Revenue Surge in 2025
Premium
Company Announcements
BeOne Medicines Swings to Profit on 40% Revenue Surge in 2025
20d ago
6160
BeOne Medicines Updates HKEX Waivers and Compliance Disclosures
Premium
Company Announcements
BeOne Medicines Updates HKEX Waivers and Compliance Disclosures
1M ago
6160
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
Premium
Company Announcements
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
1M ago
6160
BeOne Medicines Aligns 2025 Results With Dual Hong Kong and U.S. Reporting Rules
Premium
Company Announcements
BeOne Medicines Aligns 2025 Results With Dual Hong Kong and U.S. Reporting Rules
1M ago
6160
BeOne Medicines Opens New 2018 Employee Share Purchase Plan Offering Period
Premium
Company Announcements
BeOne Medicines Opens New 2018 Employee Share Purchase Plan Offering Period
1M ago
6160
More HK:6160 News >

6160 News on the Web

BeOne Medicines (ONC) Receives a Buy from Truist Financial
TipRanks News
Bullish
RBC Capital Keeps Their Buy Rating on BeOne Medicines (ONC)
TipRanks News
Bullish
BeOne Medicines price target lowered to $411 from $412 at Truist
TipRanks News
Neutral
BeOne Medicines Grants RSUs to 154 Employees Under 2016 Incentive Plan
TipRanks News
Neutral
Truist Financial Remains a Buy on BeOne Medicines (ONC)
TipRanks News
Neutral
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
TipRanks News
Bullish
BeOne Medicines Swings to Profit on 40% Revenue Surge in 2025
TipRanks News
Bullish
BeOne Medicines treatment of hepatocellular carcinoma granted orphan designation
TipRanks News
Bullish

News Score - Last 7 Days

Positive
HK:6160
Sector Average
Media Buzz
This Week4 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:6160’s Media Buzz Sentiment?
4 articles about HK:6160 were published this week. In an average week, 2.5 articles are published.
    What is HK:6160’s weekly average amount of articles?
    In an average week, 2.5 articles about HK:6160 are published.
      What is HK:6160’s News Sentiment?
      100% of articles about HK:6160 were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        STAAStaar Surgical
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week